Acute	O
clinical	O
adverse	B:C0392615
radiation	I:C0392615
effects	I:C0392615
after	O
Gamma	O
Knife	I:C2960266
surgery	I:C2960266
for	O
vestibular	O
schwannomas	I:C0027859
.	O

Acute	O
clinical	O
adverse	O
radiation	I:C0392615
effects	I:C0392615
after	O
Gamma	B:C2960266
Knife	I:C2960266
surgery	I:C2960266
for	O
vestibular	O
schwannomas	I:C0027859
.	O

Acute	O
clinical	O
adverse	O
radiation	I:C0392615
effects	I:C0392615
after	O
Gamma	O
Knife	I:C2960266
surgery	I:C2960266
for	O
vestibular	B:C0027859
schwannomas	I:C0027859
.	O

OBJECTIVE	O
Vestibular	B:C0027859
schwannomas	I:C0027859
(	O
Vestibular	O
schwannomas	I:C0027859
)	O
represent	O
a	O
common	O
indication	O
of	O
Gamma	O
Knife	I:C2960266
surgery	I:C2960266
(	O
Gamma	O
Knife	I:C2960266
surgery	I:C2960266
)	O
.	O

OBJECTIVE	O
Vestibular	O
schwannomas	I:C0027859
(	O
Vestibular	B:C0027859
schwannomas	I:C0027859
)	O
represent	O
a	O
common	O
indication	O
of	O
Gamma	O
Knife	I:C2960266
surgery	I:C2960266
(	O
Gamma	O
Knife	I:C2960266
surgery	I:C2960266
)	O
.	O

OBJECTIVE	O
Vestibular	O
schwannomas	I:C0027859
(	O
Vestibular	O
schwannomas	I:C0027859
)	O
represent	O
a	O
common	O
indication	O
of	O
Gamma	B:C2960266
Knife	I:C2960266
surgery	I:C2960266
(	O
Gamma	O
Knife	I:C2960266
surgery	I:C2960266
)	O
.	O

OBJECTIVE	O
Vestibular	O
schwannomas	I:C0027859
(	O
Vestibular	O
schwannomas	I:C0027859
)	O
represent	O
a	O
common	O
indication	O
of	O
Gamma	O
Knife	I:C2960266
surgery	I:C2960266
(	O
Gamma	B:C2960266
Knife	I:C2960266
surgery	I:C2960266
)	O
.	O

While	O
most	O
studies	B:C2603343
focus	O
on	O
the	O
long	O
-	O
term	O
morbidity	O
and	O
adverse	O
radiation	I:C0392615
effects	I:C0392615
(	O
adverse	O
radiation	I:C0392615
effects	I:C0392615
)	O
,	O
none	O
describe	O
the	O
acute	O
clinical	O
adverse	O
radiation	I:C0392615
effects	I:C0392615
that	O
might	O
appear	O
on	O
a	O
short	O
-	O
term	O
basis	O
.	O

While	O
most	O
studies	O
focus	O
on	O
the	O
long	O
-	O
term	O
morbidity	O
and	O
adverse	B:C0392615
radiation	I:C0392615
effects	I:C0392615
(	O
adverse	O
radiation	I:C0392615
effects	I:C0392615
)	O
,	O
none	O
describe	O
the	O
acute	O
clinical	O
adverse	O
radiation	I:C0392615
effects	I:C0392615
that	O
might	O
appear	O
on	O
a	O
short	O
-	O
term	O
basis	O
.	O

While	O
most	O
studies	O
focus	O
on	O
the	O
long	O
-	O
term	O
morbidity	O
and	O
adverse	O
radiation	I:C0392615
effects	I:C0392615
(	O
adverse	B:C0392615
radiation	I:C0392615
effects	I:C0392615
)	O
,	O
none	O
describe	O
the	O
acute	O
clinical	O
adverse	O
radiation	I:C0392615
effects	I:C0392615
that	O
might	O
appear	O
on	O
a	O
short	O
-	O
term	O
basis	O
.	O

While	O
most	O
studies	O
focus	O
on	O
the	O
long	O
-	O
term	O
morbidity	O
and	O
adverse	O
radiation	I:C0392615
effects	I:C0392615
(	O
adverse	O
radiation	I:C0392615
effects	I:C0392615
)	O
,	O
none	O
describe	O
the	O
acute	O
clinical	O
adverse	B:C0392615
radiation	I:C0392615
effects	I:C0392615
that	O
might	O
appear	O
on	O
a	O
short	O
-	O
term	O
basis	O
.	O

These	O
types	O
of	O
events	O
are	O
investigated	O
,	O
and	O
their	O
incidence	O
,	O
type	O
,	O
and	O
outcomes	B:C0086750
are	O
reported	O
in	O
the	O
present	O
paper	O
.	O

These	O
types	O
of	O
events	O
are	O
investigated	O
,	O
and	O
their	O
incidence	O
,	O
type	O
,	O
and	O
outcomes	O
are	O
reported	B:C0684224
in	O
the	O
present	O
paper	O
.	O

The	O
included	O
patients	O
were	O
treated	O
between	O
July	O
2010	O
and	O
March	O
2016	O
,	O
underwent	O
at	O
least	O
6	O
months	O
of	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
,	O
and	O
presented	O
with	O
a	O
disabling	O
symptom	O
during	O
the	O
first	O
6	O
months	O
after	O
Gamma	O
Knife	I:C2960266
surgery	I:C2960266
that	O
affected	O
their	O
quality	O
of	O
life	O
.	O

The	O
included	O
patients	O
were	O
treated	O
between	O
July	O
2010	O
and	O
March	O
2016	O
,	O
underwent	O
at	O
least	O
6	O
months	O
of	O
follow	O
-	I:C1522577
up	I:C1522577
,	O
and	O
presented	O
with	O
a	O
disabling	O
symptom	B:C1457887
during	O
the	O
first	O
6	O
months	O
after	O
Gamma	O
Knife	I:C2960266
surgery	I:C2960266
that	O
affected	O
their	O
quality	O
of	O
life	O
.	O

The	O
included	O
patients	O
were	O
treated	O
between	O
July	O
2010	O
and	O
March	O
2016	O
,	O
underwent	O
at	O
least	O
6	O
months	O
of	O
follow	O
-	I:C1522577
up	I:C1522577
,	O
and	O
presented	O
with	O
a	O
disabling	O
symptom	O
during	O
the	O
first	O
6	O
months	O
after	O
Gamma	B:C2960266
Knife	I:C2960266
surgery	I:C2960266
that	O
affected	O
their	O
quality	O
of	O
life	O
.	O

The	O
timing	O
of	O
appearance	O
,	O
as	O
well	O
as	O
the	O
type	O
of	O
main	O
symptom	B:C1457887
and	O
outcome	O
,	O
were	O
noted	O
.	O

The	O
timing	O
of	O
appearance	O
,	O
as	O
well	O
as	O
the	O
type	O
of	O
main	O
symptom	O
and	O
outcome	B:C0086750
,	O
were	O
noted	O
.	O

Thirty	O
-	O
five	O
(	O
22	O
%	O
)	O
of	O
159	O
patients	O
who	O
fulfilled	O
the	O
inclusion	O
criteria	O
had	O
acute	O
clinical	O
adverse	B:C0392615
radiation	I:C0392615
effects	I:C0392615
.	O

The	O
mean	O
followup	B:C1522577
period	O
was	O
30	O
months	O
(	O
range	O
6-	O
49.2	O
months	O
)	O
.	O

In	O
patients	O
with	O
de	O
novo	O
symptoms	B:C1457887
,	O
the	O
more	O
frequent	O
symptoms	O
were	O
vertigo	O
(	O
n	O
=	O
4	O
;	O
11.4	O
%	O
)	O
and	O
gait	O
disturbance	I:C0575081
(	O
n	O
=	O
3	O
;	O
8.6	O
%	O
)	O
.	O

In	O
patients	O
with	O
de	O
novo	O
symptoms	O
,	O
the	O
more	O
frequent	O
symptoms	B:C1457887
were	O
vertigo	O
(	O
n	O
=	O
4	O
;	O
11.4	O
%	O
)	O
and	O
gait	O
disturbance	I:C0575081
(	O
n	O
=	O
3	O
;	O
8.6	O
%	O
)	O
.	O

In	O
patients	O
with	O
de	O
novo	O
symptoms	O
,	O
the	O
more	O
frequent	O
symptoms	O
were	O
vertigo	B:C0042571
(	O
n	O
=	O
4	O
;	O
11.4	O
%	O
)	O
and	O
gait	O
disturbance	I:C0575081
(	O
n	O
=	O
3	O
;	O
8.6	O
%	O
)	O
.	O

In	O
patients	O
with	O
de	O
novo	O
symptoms	O
,	O
the	O
more	O
frequent	O
symptoms	O
were	O
vertigo	O
(	O
n	O
=	O
4	O
;	O
11.4	O
%	O
)	O
and	O
gait	B:C0575081
disturbance	I:C0575081
(	O
n	O
=	O
3	O
;	O
8.6	O
%	O
)	O
.	O

The	O
exacerbation	B:C0235874
of	O
a	O
preexisting	O
symptom	O
was	O
more	O
frequently	O
related	O
to	O
hearing	O
loss	I:C3887873
(	O
n	O
=	O
10	O
;	O
28.6	O
%	O
)	O
,	O
followed	O
by	O
gait	O
disturbance	I:C0575081
(	O
n	O
=	O
7	O
;	O
20	O
%	O
)	O
and	O
vertigo	O
(	O
n	O
=	O
3	O
,	O
8.6	O
%	O
)	O
.	O

The	O
exacerbation	O
of	O
a	O
preexisting	O
symptom	B:C1457887
was	O
more	O
frequently	O
related	O
to	O
hearing	O
loss	I:C3887873
(	O
n	O
=	O
10	O
;	O
28.6	O
%	O
)	O
,	O
followed	O
by	O
gait	O
disturbance	I:C0575081
(	O
n	O
=	O
7	O
;	O
20	O
%	O
)	O
and	O
vertigo	O
(	O
n	O
=	O
3	O
,	O
8.6	O
%	O
)	O
.	O

The	O
exacerbation	O
of	O
a	O
preexisting	O
symptom	O
was	O
more	O
frequently	O
related	O
to	O
hearing	B:C3887873
loss	I:C3887873
(	O
n	O
=	O
10	O
;	O
28.6	O
%	O
)	O
,	O
followed	O
by	O
gait	O
disturbance	I:C0575081
(	O
n	O
=	O
7	O
;	O
20	O
%	O
)	O
and	O
vertigo	O
(	O
n	O
=	O
3	O
,	O
8.6	O
%	O
)	O
.	O

The	O
exacerbation	O
of	O
a	O
preexisting	O
symptom	O
was	O
more	O
frequently	O
related	O
to	O
hearing	O
loss	I:C3887873
(	O
n	O
=	O
10	O
;	O
28.6	O
%	O
)	O
,	O
followed	O
by	O
gait	B:C0575081
disturbance	I:C0575081
(	O
n	O
=	O
7	O
;	O
20	O
%	O
)	O
and	O
vertigo	O
(	O
n	O
=	O
3	O
,	O
8.6	O
%	O
)	O
.	O

The	O
exacerbation	O
of	O
a	O
preexisting	O
symptom	O
was	O
more	O
frequently	O
related	O
to	O
hearing	O
loss	I:C3887873
(	O
n	O
=	O
10	O
;	O
28.6	O
%	O
)	O
,	O
followed	O
by	O
gait	O
disturbance	I:C0575081
(	O
n	O
=	O
7	O
;	O
20	O
%	O
)	O
and	O
vertigo	B:C0042571
(	O
n	O
=	O
3	O
,	O
8.6	O
%	O
)	O
.	O

In	O
the	O
univariate	O
logistic	O
regression	O
analysis	O
,	O
the	O
following	O
factors	O
were	O
statistically	O
significant	O
:	O
age	O
(	O
p	O
=	O
0.002	O
;	O
odds	O
ratio	O
[	O
OR	O
]	O
0.96	O
)	O
,	O
hearing	O
at	O
baseline	O
by	O
Gardner	B:C0451213
-	I:C0451213
Robertson	I:C0451213
(	O
Gardner	O
-	I:C0451213
Robertson	I:C0451213
)	O
class	O
(	O
p	O
=	O
0.006	O
;	O
OR	O
0.21	O
)	O
,	O
pure	O
tone	O
average	O
at	O
baseline	O
(	O
p	O
=	O
0.006	O
;	O
OR	O
0.97	O
)	O
,	O
and	O
Koos	O
grade	I:C0349674
at	O
baseline	O
(	O
with	O
Koos	O
Grade	I:C0349674
I	I:C0349674
used	O
as	O
a	O
reference	O
)	O
(	O
for	O
Koos	O
Grade	I:C0349674
II	I:C0349674
,	O
OR	O
0.17	O
and	O
p	O
=	O
0.002	O
;	O
for	O
Koos	O
Grade	I:C0349674
III	I:C0349674
,	O
OR	O
0.42	O
and	O
p	O
=	O
0.05	O
)	O
.	O

In	O
the	O
univariate	O
logistic	O
regression	O
analysis	O
,	O
the	O
following	O
factors	O
were	O
statistically	O
significant	O
:	O
age	O
(	O
p	O
=	O
0.002	O
;	O
odds	O
ratio	O
[	O
OR	O
]	O
0.96	O
)	O
,	O
hearing	O
at	O
baseline	O
by	O
Gardner	O
-	I:C0451213
Robertson	I:C0451213
(	O
Gardner	B:C0451213
-	I:C0451213
Robertson	I:C0451213
)	O
class	O
(	O
p	O
=	O
0.006	O
;	O
OR	O
0.21	O
)	O
,	O
pure	O
tone	O
average	O
at	O
baseline	O
(	O
p	O
=	O
0.006	O
;	O
OR	O
0.97	O
)	O
,	O
and	O
Koos	O
grade	I:C0349674
at	O
baseline	O
(	O
with	O
Koos	O
Grade	I:C0349674
I	I:C0349674
used	O
as	O
a	O
reference	O
)	O
(	O
for	O
Koos	O
Grade	I:C0349674
II	I:C0349674
,	O
OR	O
0.17	O
and	O
p	O
=	O
0.002	O
;	O
for	O
Koos	O
Grade	I:C0349674
III	I:C0349674
,	O
OR	O
0.42	O
and	O
p	O
=	O
0.05	O
)	O
.	O

In	O
the	O
univariate	O
logistic	O
regression	O
analysis	O
,	O
the	O
following	O
factors	O
were	O
statistically	O
significant	O
:	O
age	O
(	O
p	O
=	O
0.002	O
;	O
odds	O
ratio	O
[	O
OR	O
]	O
0.96	O
)	O
,	O
hearing	O
at	O
baseline	O
by	O
Gardner	O
-	I:C0451213
Robertson	I:C0451213
(	O
Gardner	O
-	I:C0451213
Robertson	I:C0451213
)	O
class	O
(	O
p	O
=	O
0.006	O
;	O
OR	O
0.21	O
)	O
,	O
pure	O
tone	O
average	O
at	O
baseline	O
(	O
p	O
=	O
0.006	O
;	O
OR	O
0.97	O
)	O
,	O
and	O
Koos	B:C0349674
grade	I:C0349674
at	O
baseline	O
(	O
with	O
Koos	O
Grade	I:C0349674
I	I:C0349674
used	O
as	O
a	O
reference	O
)	O
(	O
for	O
Koos	O
Grade	I:C0349674
II	I:C0349674
,	O
OR	O
0.17	O
and	O
p	O
=	O
0.002	O
;	O
for	O
Koos	O
Grade	I:C0349674
III	I:C0349674
,	O
OR	O
0.42	O
and	O
p	O
=	O
0.05	O
)	O
.	O

In	O
the	O
univariate	O
logistic	O
regression	O
analysis	O
,	O
the	O
following	O
factors	O
were	O
statistically	O
significant	O
:	O
age	O
(	O
p	O
=	O
0.002	O
;	O
odds	O
ratio	O
[	O
OR	O
]	O
0.96	O
)	O
,	O
hearing	O
at	O
baseline	O
by	O
Gardner	O
-	I:C0451213
Robertson	I:C0451213
(	O
Gardner	O
-	I:C0451213
Robertson	I:C0451213
)	O
class	O
(	O
p	O
=	O
0.006	O
;	O
OR	O
0.21	O
)	O
,	O
pure	O
tone	O
average	O
at	O
baseline	O
(	O
p	O
=	O
0.006	O
;	O
OR	O
0.97	O
)	O
,	O
and	O
Koos	O
grade	I:C0349674
at	O
baseline	O
(	O
with	O
Koos	B:C0349674
Grade	I:C0349674
I	I:C0349674
used	O
as	O
a	O
reference	O
)	O
(	O
for	O
Koos	O
Grade	I:C0349674
II	I:C0349674
,	O
OR	O
0.17	O
and	O
p	O
=	O
0.002	O
;	O
for	O
Koos	O
Grade	I:C0349674
III	I:C0349674
,	O
OR	O
0.42	O
and	O
p	O
=	O
0.05	O
)	O
.	O

In	O
the	O
univariate	O
logistic	O
regression	O
analysis	O
,	O
the	O
following	O
factors	O
were	O
statistically	O
significant	O
:	O
age	O
(	O
p	O
=	O
0.002	O
;	O
odds	O
ratio	O
[	O
OR	O
]	O
0.96	O
)	O
,	O
hearing	O
at	O
baseline	O
by	O
Gardner	O
-	I:C0451213
Robertson	I:C0451213
(	O
Gardner	O
-	I:C0451213
Robertson	I:C0451213
)	O
class	O
(	O
p	O
=	O
0.006	O
;	O
OR	O
0.21	O
)	O
,	O
pure	O
tone	O
average	O
at	O
baseline	O
(	O
p	O
=	O
0.006	O
;	O
OR	O
0.97	O
)	O
,	O
and	O
Koos	O
grade	I:C0349674
at	O
baseline	O
(	O
with	O
Koos	O
Grade	I:C0349674
I	I:C0349674
used	O
as	O
a	O
reference	O
)	O
(	O
for	O
Koos	B:C0349674
Grade	I:C0349674
II	I:C0349674
,	O
OR	O
0.17	O
and	O
p	O
=	O
0.002	O
;	O
for	O
Koos	O
Grade	I:C0349674
III	I:C0349674
,	O
OR	O
0.42	O
and	O
p	O
=	O
0.05	O
)	O
.	O

In	O
the	O
univariate	O
logistic	O
regression	O
analysis	O
,	O
the	O
following	O
factors	O
were	O
statistically	O
significant	O
:	O
age	O
(	O
p	O
=	O
0.002	O
;	O
odds	O
ratio	O
[	O
OR	O
]	O
0.96	O
)	O
,	O
hearing	O
at	O
baseline	O
by	O
Gardner	O
-	I:C0451213
Robertson	I:C0451213
(	O
Gardner	O
-	I:C0451213
Robertson	I:C0451213
)	O
class	O
(	O
p	O
=	O
0.006	O
;	O
OR	O
0.21	O
)	O
,	O
pure	O
tone	O
average	O
at	O
baseline	O
(	O
p	O
=	O
0.006	O
;	O
OR	O
0.97	O
)	O
,	O
and	O
Koos	O
grade	I:C0349674
at	O
baseline	O
(	O
with	O
Koos	O
Grade	I:C0349674
I	I:C0349674
used	O
as	O
a	O
reference	O
)	O
(	O
for	O
Koos	O
Grade	I:C0349674
II	I:C0349674
,	O
OR	O
0.17	O
and	O
p	O
=	O
0.002	O
;	O
for	O
Koos	B:C0349674
Grade	I:C0349674
III	I:C0349674
,	O
OR	O
0.42	O
and	O
p	O
=	O
0.05	O
)	O
.	O

The	O
following	O
were	O
not	O
statistically	O
significant	O
but	O
showed	O
a	O
tendency	O
toward	O
significance	O
:	O
the	O
number	O
of	O
isocenters	B:C1881275
(	O
p	O
=	O
0.06	O
;	O
OR	O
0.94	O
)	O
and	O
the	O
maximal	O
dose	O
received	O
by	O
the	O
cochlea	O
(	O
p	O
=	O
0.07	O
;	O
OR	O
0.74	O
)	O
.	O

The	O
following	O
were	O
not	O
statistically	O
significant	O
but	O
showed	O
a	O
tendency	O
toward	O
significance	O
:	O
the	O
number	O
of	O
isocenters	O
(	O
p	O
=	O
0.06	O
;	O
OR	O
0.94	O
)	O
and	O
the	O
maximal	O
dose	O
received	O
by	O
the	O
cochlea	B:C0009197
(	O
p	O
=	O
0.07	O
;	O
OR	O
0.74	O
)	O
.	O

Fractional	B:C0034980
polynomial	I:C0034980
regression	I:C0034980
analysis	I:C0034980
showed	O
a	O
nonlinear	O
relationship	O
between	O
the	O
outcome	O
and	O
the	O
radiation	O
dose	O
rate	O
(	O
minimum	O
reached	O
at	O
a	O
cutoff	O
of	O
2.5	O
Gy	O
/	O
minute	O
)	O
and	O
the	O
maximal	O
vestibular	O
dose	O
(	O
maximum	O
reached	O
at	O
a	O
cutoff	O
of	O
8	O
Gy	O
)	O
,	O
but	O
the	O
small	O
sample	O
size	O
precludes	O
a	O
detailed	O
analysis	O
of	O
the	O
former	O
.	O

Fractional	O
polynomial	I:C0034980
regression	I:C0034980
analysis	I:C0034980
showed	O
a	O
nonlinear	O
relationship	O
between	O
the	O
outcome	B:C0086750
and	O
the	O
radiation	O
dose	O
rate	O
(	O
minimum	O
reached	O
at	O
a	O
cutoff	O
of	O
2.5	O
Gy	O
/	O
minute	O
)	O
and	O
the	O
maximal	O
vestibular	O
dose	O
(	O
maximum	O
reached	O
at	O
a	O
cutoff	O
of	O
8	O
Gy	O
)	O
,	O
but	O
the	O
small	O
sample	O
size	O
precludes	O
a	O
detailed	O
analysis	O
of	O
the	O
former	O
.	O

Fractional	O
polynomial	I:C0034980
regression	I:C0034980
analysis	I:C0034980
showed	O
a	O
nonlinear	O
relationship	O
between	O
the	O
outcome	O
and	O
the	O
radiation	O
dose	O
rate	O
(	O
minimum	O
reached	O
at	O
a	O
cutoff	O
of	O
2.5	O
Gy	O
/	O
minute	O
)	O
and	O
the	O
maximal	O
vestibular	B:C0042606
dose	O
(	O
maximum	O
reached	O
at	O
a	O
cutoff	O
of	O
8	O
Gy	O
)	O
,	O
but	O
the	O
small	O
sample	O
size	O
precludes	O
a	O
detailed	O
analysis	O
of	O
the	O
former	O
.	O

Fractional	O
polynomial	I:C0034980
regression	I:C0034980
analysis	I:C0034980
showed	O
a	O
nonlinear	O
relationship	O
between	O
the	O
outcome	O
and	O
the	O
radiation	O
dose	O
rate	O
(	O
minimum	O
reached	O
at	O
a	O
cutoff	O
of	O
2.5	O
Gy	O
/	O
minute	O
)	O
and	O
the	O
maximal	O
vestibular	O
dose	O
(	O
maximum	O
reached	O
at	O
a	O
cutoff	O
of	O
8	O
Gy	O
)	O
,	O
but	O
the	O
small	O
sample	O
size	O
precludes	O
a	O
detailed	O
analysis	B:C0936012
of	O
the	O
former	O
.	O

The	O
clinical	O
acute	O
adverse	B:C0392615
radiation	I:C0392615
effects	I:C0392615
disappeared	O
in	O
32	O
(	O
91.4	O
%	O
)	O
patients	O
during	O
the	O
first	O
6	O
months	O
after	O
appearance	O
.	O

Permanent	O
and	O
somewhat	O
disabling	O
morbidity	O
was	O
found	O
in	O
3	O
cases	O
(	O
1.9	O
%	O
from	O
the	O
whole	O
series	O
)	O
:	O
1	O
each	O
with	O
complete	B:C0581883
hearing	I:C0581883
loss	I:C0581883
(	O
GR	O
Class	I:C0451213
I	I:C0451213
before	O
and	O
V	O
after	O
)	O
,	O
hemifacial	O
spasm	I:C0278152
(	O
persistent	O
but	O
alleviated	O
)	O
,	O
and	O
dysgeusia	O
.	O

Permanent	O
and	O
somewhat	O
disabling	O
morbidity	O
was	O
found	O
in	O
3	O
cases	O
(	O
1.9	O
%	O
from	O
the	O
whole	O
series	O
)	O
:	O
1	O
each	O
with	O
complete	O
hearing	I:C0581883
loss	I:C0581883
(	O
GR	B:C0451213
Class	I:C0451213
I	I:C0451213
before	O
and	O
V	O
after	O
)	O
,	O
hemifacial	O
spasm	I:C0278152
(	O
persistent	O
but	O
alleviated	O
)	O
,	O
and	O
dysgeusia	O
.	O

Permanent	O
and	O
somewhat	O
disabling	O
morbidity	O
was	O
found	O
in	O
3	O
cases	O
(	O
1.9	O
%	O
from	O
the	O
whole	O
series	O
)	O
:	O
1	O
each	O
with	O
complete	O
hearing	I:C0581883
loss	I:C0581883
(	O
GR	O
Class	I:C0451213
I	I:C0451213
before	O
and	O
V	B:C0451213
after	O
)	O
,	O
hemifacial	O
spasm	I:C0278152
(	O
persistent	O
but	O
alleviated	O
)	O
,	O
and	O
dysgeusia	O
.	O

Permanent	O
and	O
somewhat	O
disabling	O
morbidity	O
was	O
found	O
in	O
3	O
cases	O
(	O
1.9	O
%	O
from	O
the	O
whole	O
series	O
)	O
:	O
1	O
each	O
with	O
complete	O
hearing	I:C0581883
loss	I:C0581883
(	O
GR	O
Class	I:C0451213
I	I:C0451213
before	O
and	O
V	O
after	O
)	O
,	O
hemifacial	B:C0278152
spasm	I:C0278152
(	O
persistent	O
but	O
alleviated	O
)	O
,	O
and	O
dysgeusia	O
.	O

Permanent	O
and	O
somewhat	O
disabling	O
morbidity	O
was	O
found	O
in	O
3	O
cases	O
(	O
1.9	O
%	O
from	O
the	O
whole	O
series	O
)	O
:	O
1	O
each	O
with	O
complete	O
hearing	I:C0581883
loss	I:C0581883
(	O
GR	O
Class	I:C0451213
I	I:C0451213
before	O
and	O
V	O
after	O
)	O
,	O
hemifacial	O
spasm	I:C0278152
(	O
persistent	O
but	O
alleviated	O
)	O
,	O
and	O
dysgeusia	B:C0013378
.	O

Acute	O
effects	O
after	O
radiosurgery	B:C0085203
for	O
VS	O
are	O
not	O
rare	O
.	O

Acute	O
effects	O
after	O
radiosurgery	O
for	O
VS	B:C0027859
are	O
not	O
rare	O
.	O

They	O
concern	O
predominantly	O
de	O
novo	O
vertigo	B:C0042571
and	O
gait	O
disturbance	I:C0575081
and	O
the	O
exacerbation	O
of	O
preexistent	O
hearing	O
loss	I:C3887873
.	O

They	O
concern	O
predominantly	O
de	O
novo	O
vertigo	O
and	O
gait	B:C0575081
disturbance	I:C0575081
and	O
the	O
exacerbation	O
of	O
preexistent	O
hearing	O
loss	I:C3887873
.	O

They	O
concern	O
predominantly	O
de	O
novo	O
vertigo	O
and	O
gait	O
disturbance	I:C0575081
and	O
the	O
exacerbation	B:C0235874
of	O
preexistent	O
hearing	O
loss	I:C3887873
.	O

They	O
concern	O
predominantly	O
de	O
novo	O
vertigo	O
and	O
gait	O
disturbance	I:C0575081
and	O
the	O
exacerbation	O
of	O
preexistent	O
hearing	B:C3887873
loss	I:C3887873
.	O

In	O
de	O
novo	O
vestibular	B:C0042606
symptom	O
s	O
,	O
a	O
vestibular	O
dose	O
of	O
more	O
than	O
8	O

In	O
de	O
novo	O
vestibular	O
symptom	B:C1457887
s	O
,	O
a	O
vestibular	O
dose	O
of	O
more	O
than	O
8	O

In	O
de	O
novo	O
vestibular	O
symptom	O
s	O
,	O
a	O
vestibular	B:C0042606
dose	O
of	O
more	O
than	O
8	O

In	O
most	O
cases	O
,	O
none	O
of	O
these	O
effects	O
are	O
permanent	O
,	O
and	O
they	O
will	O
ultimately	O
improve	O
or	O
disappear	O
with	O
steroid	B:C0149783
therapy	I:C0149783
.	O

Permanent	O
adverse	B:C0392615
radiation	I:C0392615
effects	I:C0392615
remain	O
very	O
rare	O
.	O

